TF and lung carcinoma: The effects of the R‐Tf‐D‐LP4 peptide on glioblastoma‐derived U‐87MG, lung cancer‐derived A549, or breast cancer‐derived MDA‐MB‐231 cell xenograft mouse models were tested according to an established protocol (Fig. 6A).